強気
$8.88
シナリオ価格
$11.740
-0.598 (-5.09%)終値時点
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

LifeStance Health Group CTO Sells Shares Amid Strong Stock Performance

LifeStance Executive Share Disposition Analysis

OBIO and LFST Stocks Hit New Highs Amid Positive Analyst Sentiment

LifeStance Health Group Announces Secondary Public Offering

LifeStance Health Surpasses Q2 Earnings Expectations Driven by Clinician Growth
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).
LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。